Splenic infarction from factor V Leiden mutation

被引:0
作者
Lopez, F [1 ]
Mega, A [1 ]
Schiffman, F [1 ]
Sweeney, J [1 ]
机构
[1] Brown Univ, Miriam Hosp, Sch Med, Dept Hematol Oncol, Providence, RI 02906 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:62 / 63
页数:2
相关论文
共 5 条
[1]  
BAUER K, 1998, HEMATOLOGY, P261
[2]   VENOUS THROMBOSIS DUE TO POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - LEIDEN THROMBOPHILIA STUDY [J].
KOSTER, T ;
ROSENDAAL, FR ;
DERONDE, H ;
BRIET, E ;
VANDENBROUCKE, JP ;
BERTINA, RM .
LANCET, 1993, 342 (8886-7) :1503-1506
[3]   Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women [J].
Rosendaal, FR ;
Siscovick, DS ;
Schwartz, SM ;
Beverly, RK ;
Psaty, BM ;
Longstreth, WT ;
Raghunathan, TE ;
Koepsell, TD ;
Reitsma, PH .
BLOOD, 1997, 89 (08) :2817-2821
[4]   A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM [J].
SCHULMAN, S ;
RHEDIN, AS ;
LINDMARKER, P ;
CARLSSON, A ;
LARFARS, G ;
NICOL, P ;
LOOGNA, E ;
SVENSSON, E ;
LJUNGBERG, B ;
WALTER, H ;
VIERING, S ;
NORDLANDER, S ;
LEIJD, B ;
JONSSON, KA ;
HJORTH, M ;
LINDER, O ;
BOBERG, J ;
GUSTAFSSON, C ;
GRONDAHL, A ;
TORNEBOHM, E ;
JOHANSSON, M ;
LOCKNER, D ;
JOHNSSON, H ;
KOBOSKO, J ;
MALMROS, B ;
ARCINI, N ;
SAAW, J ;
STIG, R ;
WILHELMSSON, S ;
OHLSSON, A ;
MALMQVIST, K ;
ALKHALILI, F ;
PETRESCU, A ;
BROHULT, J ;
HULTING, J ;
EKLUND, SG ;
DAHLIN, L ;
MARJANOVICS, B ;
MALM, C ;
LINDGREN, A ;
FAGRELL, B ;
KALLNER, M ;
GRANQVIST, S ;
WIMAN, B ;
EGBERG, N ;
WADMAN, B ;
SNYDER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25) :1661-1665
[5]   INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].
VANDENBROUCKE, JP ;
KOSTER, T ;
BRIET, E ;
REITSMA, PH ;
BERTINA, RM ;
ROSENDAAL, FR .
LANCET, 1994, 344 (8935) :1453-1457